Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.

Niederkorn A, Wackernagel W, Artl M, Schwantzer G, Aigner B, Richtig E.

Acta Ophthalmol. 2014 Dec;92(8):e696-7. doi: 10.1111/aos.12432. Epub 2014 Apr 28. No abstract available.

2.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.

Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.

Ann Oncol. 2014 Mar;25(3):742-6. doi: 10.1093/annonc/mdt585. Epub 2014 Feb 7.

3.

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.

Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB.

Br J Cancer. 2002 Oct 7;87(8):840-5.

4.

Treatment of metastatic uveal melanoma with intravenous fotemustine.

Spagnolo F, Grosso M, Picasso V, Tornari E, Pesce M, Queirolo P.

Melanoma Res. 2013 Jun;23(3):196-8. doi: 10.1097/CMR.0b013e3283610586.

PMID:
23624366
5.

Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.

Voelter V, Schalenbourg A, Pampallona S, Peters S, Halkic N, Denys A, Goitein G, Zografos L, Leyvraz S.

Melanoma Res. 2008 Jun;18(3):220-4. doi: 10.1097/CMR.0b013e32830317de.

PMID:
18477897
6.

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

Bhatia S, Moon J, Margolin KA, Weber JS, Lao CD, Othus M, Aparicio AM, Ribas A, Sondak VK.

PLoS One. 2012;7(11):e48787. doi: 10.1371/journal.pone.0048787. Epub 2012 Nov 30.

7.

Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy.

Salmon RJ, Levy C, Plancher C, Dorval T, Desjardins L, Leyvraz S, Pouillart P, Schlienger P, Servois V, Asselain B.

Eur J Surg Oncol. 1998 Apr;24(2):127-30.

PMID:
9591028
8.

Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.

Kodjikian L, Grange JD, Rivoire M.

Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):622-4. Epub 2005 Jan 14.

PMID:
15650857
9.
10.

Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.

Peters S, Voelter V, Zografos L, Pampallona S, Popescu R, Gillet M, Bosshard W, Fiorentini G, Lotem M, Weitzen R, Keilholz U, Humblet Y, Piperno-Neumann S, Stupp R, Leyvraz S.

Ann Oncol. 2006 Apr;17(4):578-83. Epub 2006 Feb 9.

PMID:
16469752
11.

[Therapy of metastatic malignant uveal melanoma].

Jäckel A, Bock M, Deichmann M, Waldmann V, Näher H.

Hautarzt. 2001 Feb;52(2):98-103. Review. German.

PMID:
11244899
12.

Variates of survival in metastatic uveal melanoma.

Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB.

J Clin Oncol. 2005 Nov 1;23(31):8076-80.

PMID:
16258106
13.

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.

Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS.

Cancer. 1995 Nov 1;76(9):1665-70.

14.

Fotemustine-dacarbazine combinations in the treatment of metastatic melanoma.

Merimsky O, Chaitchik S.

Eur J Cancer. 1993;29A(3):481-2. No abstract available.

PMID:
8398358
15.

Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.

Heusner TA, Antoch G, Wittkowski-Sterczewski A, Ladd SC, Forsting M, Verhagen R, Scheulen M.

Rofo. 2011 Dec;183(12):1151-60. doi: 10.1055/s-0031-1281743. Epub 2011 Oct 27.

PMID:
22033849
16.
17.

Medical treatment of uveal melanoma.

Queirolo P, Acquati M.

Tumori. 2007 May-Jun;93(3):suppl 27-30. Review. No abstract available.

PMID:
17679486
18.

Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study.

Farolfi A, Ridolfi L, Guidoboni M, Milandri C, Calzolari F, Scarpi E, Amadori D, Ridolfi R.

J Chemother. 2011 Oct;23(5):300-5.

PMID:
22005064
19.

Ipilimumab with fotemustine in metastatic melanoma.

Garbe C.

Lancet Oncol. 2012 Sep;13(9):851-2. doi: 10.1016/S1470-2045(12)70341-8. Epub 2012 Aug 13. No abstract available.

PMID:
22894885
20.

Temozolomide in combination with fotemustine in patients with metastatic melanoma.

Tas F, Camlica H, Topuz E.

Cancer Chemother Pharmacol. 2008 Jul;62(2):293-8. Epub 2007 Oct 2.

PMID:
17909803

Supplemental Content

Support Center